On September 12, 2025, news emerged that Vivek Ramaswamy, the founder and former CEO of Roivant Sciences, sold a substantial amount of his company stock. According to a U.S. Securities and Exchange Commission filing, Ramaswamy sold 1,195,000 shares of Roivant Sciences. The sales occurred on September 3, 2025.
Each share was sold for $12.50, totaling approximately $14,937,500 from these transactions. Ramaswamy founded Roivant Sciences in 2014 and served as its CEO until 2021. He still retained a 7.17% stake in the company prior to these sales.
Such a significant insider sale by a prominent figure like a founder can be closely scrutinized by investors. It may lead to questions about the individual's confidence in the company's near-term outlook. This event could influence market sentiment regarding Roivant Sciences.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.